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Sequence variation displayed by the human immunodeficiency virus type 1 (HIV-1) has been proposed to be linked to the
pathogenesis of acquired immunodeficiency syndrome (AIDS). To assess viral evolution during the course of infection, we
evaluated sequence variability in the env variable domains in four HIV-1-infected individuals exhibiting differing profiles of
CD41 T cell decline when followed from seroconversion until the development of AIDS or loss of followup. Proviral
sequences encoding the V3–V5 region of gp120 were obtained following PCR amplification of peripheral blood mononuclear
cell DNA and cloning. Virus in each patient was relatively homogeneous early in infection and then diverged with time, more
consistently at its nonsynonymous sites. Just prior to or coincident with a rapid decline in CD41 T cell numbers, sequences
were found with basic amino acid substitutions clustered within and downstream of the gp120 V3 domain. Within the
constraints of the current dataset, we conclude that the virus appears to continually accumulate changes in its amino acid
sequences well into the time of marked CD41 T cell decline. © 1998 Academic Press
INTRODUCTION
Accumulation of genetically diverse viral genome vari-
ants in vivo is a hallmark of lentivirus replication. Genetic
variants, introduced by the high error rate of retroviral
reverse transcriptase, are selected for by conformational
constraints imposed by viral structure, function, and im-
mune pressure (Borrow et al., 1997; Hirsch et al., 1989). In
HIV-1, considerable variation is focused in the envelope
gene, which encodes critical host–range determinants
and immune targets on the virus.
Minimal viral env gene heterogeneity is observed early
in infection via homosexual, parenteral, and perinatal
transmission routes (Ganeshan et al., 1997; McNearney
et al., 1992; Wolfs et al., 1992; Wolinsky et al., 1992, 1996;
Zhang et al., 1993; Zhu et al., 1993). This suggests the
presence of a viral population bottleneck resulting in the
establishment of infection by a single infectious unit or a
selective amplification of only one or a few variants.
However, over the course of the disease, the virus pop-
ulation turns over rapidly (Ho et al., 1995; Perelson et al.,
1996; Wei et al., 1995) and evolves to diverge 5–10% or
more within an individual and yet retain signature se-
quences identifying their phylogenetic origin.
The rate of disease progression in HIV-1 and related
infections has been associated with several factors.
These include the magnitude of viral load (Mellors et al.,
1996), enhancement of viral transcription and replication
(Connor and Ho, 1994; Furtado et al., 1995; Michael et al.,
1991; Saksela et al., 1994), emergence of more cytopathic
or pathogenic variants (Connor et al., 1993; Dewhurst et
al., 1990; Mullins et al., 1991; Schuitemaker et al., 1992;
Tersmette et al., 1988, 1989), alterations in immune pa-
rameters (Klein et al., 1995; Rinaldo et al., 1995), and in
cases of slow disease progression, transmission or per-
sistence of attenuated forms of the virus (Connor and Ho,
1994; Deacon et al., 1995; Desrosiers, 1992; Iversen et al.,
1995; Kirchhoff et al., 1995; Michael et al., 1991) or the
mutant form of the chemokine co-receptors (Smith et al.,
1997). Disease progression has also been proposed to
result from attainment of a threshold of antigenic diver-
sity in the viral quasispecies above which the immune
system is unable to respond (Nowak et al., 1991). Clonal
dominance or deceptive imprinting of the immune re-
sponse toward the viruses established early in infection,
aided in part by a saturating level of circulating viral
antigen, has also been proposed to result in a loss of
immune containment and disease progression (Ko¨hler et
al., 1992, 1994). Viral genetic diversity tends to evolve
more slowly in those progressing relatively quickly to
AIDS (Delwart et al., 1994; Liu et al., 1997; Lukashov et al.,
1995; Wolinsky et al., 1996). The hypothesis that early
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phases of disease progression are dominated by a bias
in viral evolutionary progression for nonsynonymous site
changes, then for synonymous changes when the im-
mune system collapses, has also been put forward (Bon-
hoeffer et al., 1995), although this analysis is controver-
sial (Rodrigo and Mullins, 1996).
To address the association between viral sequence
variability and disease progression, we evaluated the
evolution of sequences spanning the V3 through V5 vari-
able domains of the HIV-1 envelope gene in four patients
with differing clinical courses over the first 5–9 years of
their infection. We found low sequence diversity in the
virus population from each patient early in infection,
followed by viral diversification. Nonsynonymous and
synonymous site substitutions increased over time, al-
though notable differences in these trends were ob-
served between patients. When compared to sequences
from the virus at seroconversion, all patients showed
consistent increases in nonsynonymous substitutions.
Within the constraints of a small dataset and the length
of followup, our findings fail to show consistent selection
for amino acid sequence change early in infection, fol-
lowed by purifying selection during later stages of the
disease (Bonhoeffer et al., 1995). Rather, the amino acid
changes continue to accumulate into the time of marked
CD41 T cell decline as examined in this study.
RESULTS
Figure 1 illustrates the profile of CD41 T cell numbers
and diversity in viral nucleotide and deduced amino acid
sequences found within each time point for each of the four
patients studied, as well as these changes relative to se-
quences sampled at the seroconversion time point. Phylo-
genetic analysis showed that sequences from each patient
clustered into single well-supported separate branches
consistent with a lack of contamination between patient
samples (data not shown) (Learn et al., 1996).
Patient AD progressed to a CD41 T cell level below
200 in less than 6 years following infection, whereas
FIG. 1. Sequence variation and CD41 T cell profile. (A) The changes in CD41 T cell numbers over the course of infection and administration of
antiretroviral therapy. Also illustrated in this panel is the variation in amino acid sequences within a timepoint as well as at each timepoint compared
to sequences present in the first timepoint. (B) The proportions of nucleotide substitutions per potential dN and dS site at each timepoint. (C) dN and
dS substitutions at each timepoint compared to sequences from the first timepoint.
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patients IN and OT progressed somewhat slower, drop-
ping below 200 CD41 T cell/mm3 at about 7 years postin-
fection. Patient EH was lost to followup after 4.5 years of
infection with high CD4 cell levels (.800). AZT was
administered to patients AD, IN, and OT, but was not a
factor in sequence evaluations for patients AD and OT,
since the samples evaluated here were obtained before
or at the time of drug administration.
The diversity of viral sequences at each time point
generally increased over time (Fig. 1), notable exceptions
being timepoint G in patient EH and to a lesser extent
timepoint Q in patient OT. At these two timepoints, many
of the sequences formed a tight grouping as a result of
low nucleotide divergences (0.35% for timepoint G and
1.69% for timepoint Q), including some identical se-
quences (Fig. 3b: g6, g8, g9; Fig. 3d: q1, q6). The level of
divergence observed in these clusters is consistent with
the error rate of Taq polymerase in PCR (Eckert and
Kunkel, 1991) and, since the proviral copy number in the
PCR was not quantitated prior to deriving clones, it is
likely that these sequences resulted from resampling of
the same provirus and thus provide a falsely low esti-
mate of viral population diversity (Liu et al., 1996).
Amino acid diversity increased over the course of
infection but was somewhat variable within timepoints.
The rate of diversification relative to the first timepoint,
however, was more consistent. Similar trends were ob-
served when nucleotide substitutions were evaluated.
The rate of virus population diversification was relatively
consistent over time, although if anything, a slower rate
of change was observed in the patient that had not
progressed to disease (patient EH; Fig. 1).
An alignment of amino acid sequences sampled from
these patients (Fig. 2) shows a pattern of unique muta-
tions superimposed on a pattern of consistent changes
that in many instances distinguished different timepoints
(e.g., note the 12 consistent amino acid substitutions at
the last timepoint in patient AD). For each patient, a
separate cluster with considerable bootstrap support
was found at later stages of the observation period (Fig.
3). Thus, the virus populations appeared to have under-
gone bottlenecks or substantial replacements over time.
Partitioning the sequence variation into changes that
lead to altered amino acid sequence (dN) or silent sub-
stitutions (dS) is thought to reveal the nature of evolu-
tionary forces acting on the virus population. An overrid-
ing selective pressure for change of amino acids is
expected to be reflected in the preferential accumulation
of dN substitutions. The intra timepoint profile of both dN
and dS substitutions (Fig. 1B) was quite variable with
either high dS substitutions (patients AD and IN) or high
dN substitutions (patients EH and OT). However, as
shown in Fig. 1C, when the variability at dN and dS sites
was compared to sequences from virus at the first time-
point, dN substitutions showed a strong tendency to
increase in a linear manner in all the patients, identical to
that seen with amino acid variations (Fig. 1A). On the
other hand, the divergence in dS substitutions at each
timepoint compared to virus present early in infection
(Fig. 1C) were as variable as that seen for intra time point
profiles (Fig. 1B). Therefore, these results suggest that
virus is constantly accumulating dN substitutions as it
evolves over time.
The presence of a more heterogeneous viral popula-
tion in slow progressors versus rapid progressors has
been reported (Delwart et al., 1994; Wolinsky et al., 1996).
However, patient EH, who appears to have maintained
stable CD41 T cell numbers over the period evaluated,
shows relatively low overall virus variation. No consistent
changes associated with N-glycosylation motifs were
noted. For example, in patient AD, of the 12 motifs, only
one position accumulated changes in three or more
sequences over time that resulted in a loss of the N-
glycosylation site.
Certain amino acid positions have been shown to
determine important in vitro HIV phenotypic properties.
Extending previously published observations, Milich et
al., (1993) reported a statistically significant association
between the presence of basic amino acid substitutions
at four positions in V3 and the T-cell tropism of viral
isolates. All four patients show basic substitutions at one
or more of these positions toward later stages of infec-
tion (Fig. 2). Similarly, the amino acid at position seven in
V3 loop alignment shown in Fig. 2 (I?IGPGR) was re-
ported to be associated with V3 peptide binding (Wolfs et
al., 1991) and either resistance or enhancement of infec-
tion by human monoclonal antibodies (Kliks et al., 1993).
Variation at this position can be seen in all patients
except patient EH.
DISCUSSION
Pathogens such as HIV-1 survive in part by changing
their genetic structure rapidly to overcome host defenses
and antiretroviral agents. However, such variation is lim-
ited by the constraints of a conformational framework
that requires viral proteins to retain their function. The
chronic nature of an HIV-1 infection, the high replicative
error rate, and the extremely large turnover of virus (Ho et
al., 1995; Perelson et al., 1996; Wei et al., 1995) allow the
virus population to accumulate a large number of muta-
tions. To understand the differences in disease progres-
sion observed in HIV-1-infected individuals, as well as
the dynamics of sequence variation, a longitudinal sam-
pling of viral sequences within four individuals with dif-
fering disease progression profiles was conducted.
In agreement with previous reports (Delwart et al.,
1994; McNearney et al., 1992; Pang et al., 1992; Wolfs et
al., 1992; Wolinsky et al., 1992, 1996; Zhang et al., 1993;
Zhu et al., 1993), all four patients showed relatively low
levels of sequence heterogeneity at the first timepoint
postseroconversion. Thereafter, the viral quasispecies
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FIGURE 2—CONTINUED
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FIG. 3. Phylogenetic relationships among nucleic acid sequences sampled in each patient. The phylogenetic trees were generated using the
neighbor-joining method (Saitou and Nei, 1987) from the matrix of DNA distances for pairwise comparisons derived in PHYLIP (Felsenstein, 1993).
Sequences from the clones E2 and C3 and four other prototype viral sequences were used as an outgroup and to root the tree. Numbers at the nodes
indicate the percentage of samples (of 1000) in which an indicated node was supported in a bootstrap analysis; values $80% are shown.
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appear to become more heterogeneous as well as di-
versify away from the virus population initiating the in-
fection. The dynamics of such evolution can provide keys
to a better understanding of the pathogenic process. For
example, a constant rate of viral evolution during the
entire disease course suggests that host immune status
and other host-related parameters are of lesser impor-
tance than if deviations from a constant rate during
different stages of disease is found. Within the con-
straints of the length and frequency of followup and the
number of sequences examined in this study, there ap-
pears to be a gradual and constant level of virus diver-
sification into late stages of infection, where CD41 T cell
numbers decline precipitously. The consistency may be
greater than shown in Fig. 1, if indeed the sample diver-
sity is artificially low due to template resampling.
The antigenic diversity threshold theory (Nowak et al.,
1991) predicts that the virus population continues to
accumulate mutations in response to immune pressure
until a point that the immune response capacity is satu-
rated and fast replicating viral variants are expected to
predominate. Alternatively, the evolution of virulent forms
of the virus (Connor et al., 1993; Dewhurst et al., 1990;
Mullins et al., 1991; Schuitemaker et al., 1992; Tersmette
et al., 1988, 1989) could be associated with occult repli-
cation and ultimate outgrowth of a more virulent variant
leading to the development of AIDS. In both of these
scenarios, the presence of immune driven selection is
expected to be reflected in the preferential accumulation
of nonsynonymous substitutions while such a bias would
be absent following the advancement of the disease
state. The clonal dominance theory (Ko¨hler et al., 1992,
1994), on the other hand, predicts an absence of selec-
tion by the immune pressure since the immune response
is directed at the sequences that initiated the infection. A
low level of dS relative to dN has been interpreted as
evidence for positive selection (Bonhoeffer et al., 1995).
Furthermore, when viewed in the context of the presence
of a preponderance of synonymous substitutions in viral
genes evolving at a fast rate (Gojobori et al., 1990), it
remains to be seen if the presence of equivalent substi-
tutions at dN and dS sites may be considered in itself as
evidence of selection for change in amino acid se-
quence.
In the current study, both dN and dS substitutions
generally increase over time at similar rates (Fig. 1).
However, there was no apparent consistency in the
trends among the patients. While the presence of posi-
tive selection for change over the disease course has
been suggested (Bonhoeffer et al., 1995; Rodrigo and
Mullins, 1996; Wolinsky et al., 1996), the lack of clearly
identifiable patterns of amino acid sequence change
among the patients reveals a need to further augment
information on sequence variation in terms of its biologic
implications.
MATERIALS AND METHODS
Patient selection. Four HIV-1-infected homosexual
men were selected from the Pittsburgh cohort of the
Multicenter AIDS Cohort Study (MACS). Each PBMC
specimen was identified by a letter that was ordered in a
series and the patient designators were derived from the
first and last letter corresponding to samples from that
patient. For example, four samples were obtained from
patient AD (samples A, B, C, and D), four for patient EH
(samples E, F, G and H), etc. Patients AD and IN showed
a marked decline in CD41 T cell numbers over the
course of the first 5 years of infection. Patient EH main-
tained stable CD41 T cell numbers for 4.3 years follow-
ing seroconversion, before loss to followup. Patient OT
also maintained stable CD41 T cells for 6.5 years before
experiencing a marked decline leading to AIDS 8.4 years
after seroconversion. Zidovudine was administered to
three of the patients as indicated in Fig. 1, but was not a
factor in influencing viral diversity estimations in two of
these patients. A total of 19 time points from the four
individuals were analyzed.
PCR amplification and sequencing. Between 100,000
and 250,000 PBMC were lysed in a quick lysis solution of
0.5% NP-40 and Tween 20 (Ehrlich et al., 1990) and used
in a nested PCR amplification protocol that reproducibly
resulted in amplification of less than 10 copies of tem-
plate DNA (data not shown). The outer primers used
were (7060) 59-CAATGCTAAAACCATAATAGTACA and
(7735) 59-TCTTCTCTTTGCCTTGGTGGGT. The internal
primer pairs used in a second round of PCR were (7088)
59-AACCAATCTGCAGAAATTAATTGTACGCGTCCCA-
ACAAC and (7645) 59-ATCTCCTCCTCCCGGCCGGAA-
GATCTCGGA [numbers in parentheses indicate the po-
sition of the 59 base of the oligonucleotide in the se-
quence of prototype strain HXB2 (Genbank Accession
No. K03455) and the underlined bases correspond to
alterations introduced in the primer sequence to facili-
tate recognition by restriction endonuclease]. Procedural
safeguards were employed against sample contamina-
tion (Ehrlich, 1991; Ehrlich et al., 1991). Control reactions
with no template were included in every amplification
experiment to test for the presence of carryover contam-
ination. The specificity of amplified products was estab-
lished by liquid hybridization using a radioactively la-
beled oligonucleotide specific for amplified sequences
and gel retardation analysis followed by autoradiography
(Ehrlich et al., 1990; Sirko, 1994). Amplified products were
cloned into pBluescript (Stratagene, La Jolla, CA) follow-
ing digestion with restriction endonucleases or into the
TA cloning vector pCRII (Invitrogen, San Diego, CA). Plas-
mids were sequenced on an ABI 373A automated se-
quencer using cycle sequencing with dye terminator
chemistry (Perkin–Elmer; Norwalk CT). From each time
point, up to 8 sequences encoding an open reading
frame were used for further analysis. A total of 119
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sequences were examined and deposited in GenBank
(Accession Nos. U15804–U15922).
Sequence analysis. All sequences determined were
compared to the GenBank sequence database (Release
91.0) using the FASTA program (Pearson and Lipman,
1988). The variation among amino acid sequences was
computed as a mean of the unweighted Hamming dis-
tances between pairs of amino acid sequences using
MEGA software (Kumar et al., 1994). Variation in nucleic
acid sequences was computed using the two-parameter
distance method of Kimura (1980), as implemented in the
MEGA program (Kumar et al., 1994).
Phylogenetic relationships among sequences were
evaluated using the neighbor-joining method (Saitou and
Nei, 1987) implemented in PHYLIP Version 3.5 (Felsen-
stein, 1993). Sequences from each patient formed mono-
phyletic groups, with none greater than 93.6% identical to
sequences from other patients or those in the GenBank
database. These observations are consistent with a lack
of sample mix up between individuals and from other
strains present in the laboratory (Learn et al., 1996).
Proportion of nonsynonymous substitutions per poten-
tial nonsynonymous site (dN) and the proportion of syn-
onymous substitutions per potential synonymous site
(dS) were calculated with Jukes-Cantor correction using
MEGA software (Kumar et al., 1994).
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